Physician profile
Ethan Hampton
NPI 1437582160
$7,847.31
in general payments reported to CMS, 2019-2025
43 companies · $778 in 2025
The $778 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,449 · 2022: $1,663 · 2023: $1,887 · 2024: $2,070 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,735.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $985.35 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $935.52 | 2021-2025 | |
| Novo Nordisk INC | $865.61 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $777.34 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $563.14 | 2022-2025 | Freestyle Libre 3 |
| Amgen INC. | $529.68 | 2021-2025 | Evenity, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $449.54 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Glaxosmithkline, LLC. | $392.98 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $359.50 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $245.63 | 2021-2024 | Spravato, Xarelto |
| Amarin Pharma, INC. | $181.82 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $180.21 | 2022-2025 | |
| Exact Sciences Corporation | $139.04 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $113.06 | 2022 | |
| Phathom Pharmaceuticals, INC. | $111.80 | 2024-2025 | Voquezna |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Hampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.